Do you want to skip to content? Skip to content
България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق Australia Australia India India Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Indonesia Indonesia 日本 日本 대한민국 대한민국 ไทย ไทย Việt Nam Việt Nam 中国大陆 中国大陆 中国香港特别行政区 中国香港特别行政区 中国台湾 中国台湾
False /oidc-signin/en-gb/ България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق Australia Australia India India Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Indonesia Indonesia 日本 日本 대한민국 대한민국 ไทย ไทย Việt Nam Việt Nam 中国大陆 中国大陆 中国香港特别行政区 中国香港特别行政区 中国台湾 中国台湾
text ;

More wounds healed. Faster healing. Fewer adverse events¹⁻²

RCT evidence shows Aquacel® Ag+ Extra™ heals more wounds, heals wounds faster and with >3x fewer adverse events versus non-silver dressings.¹⁻² NICE reviewed cost-modelling shows Aquacel® Ag+ saves >£500 per patient to treat an infected leg ulcer.³
Contact us

Better, faster and safer¹ ²

icon

Better: 35% more wounds healed vs Cutimed® Sorbact®¹

RCT: VLUs treated with Aquacel® Ag+ were 35% more likely to heal vs Cutimed® (p=0.0031) – incl. non-infected wounds.*

Get in touch Get in touch

chart, line chart

Better: healed more hard-to-heal VLUs than UrgoStart®¹⁻²

At 8 wks, UrgoStart healed 6.5% of VLUs²; in the same time Aquacel® Ag+ healed ~53% of hard to heal VLUs.¹

Learn more Learn more

shape, arrow

Faster: wounds that heal, heal quicker¹

Aquacel® Ag+ heals more wounds faster (a median of 2 wks quicker). VLUs cost NHS £205.68/patient/wk (2017/18).⁴

Contact us Contact us

diagram

Safer: >3x fewer adverse events vs non-silver dressings¹⁻²

Aquacel® Ag+ patients had fewer adverse events vs Cutimed® & UrgoStart (incl. infection, bleeding, periwound eczema).

Get in touch Get in touch

More Than Silver™: how it works

Tackling biofilm as a barrier in hard-to-heal wounds
logo, company name diagram ;

NICE-published cost comparison⁴

The NICE Late Stage Assessment includes a health economic analysis of infected leg ulcers using different types of antimicrobial agents.

  1. Save >£500 per patient vs all other silver dressings: Aquacel Ag+ was associated with a >£500 saving per patient versus all other silvers. This was attributed to faster healing rates.

  2. Faster healing = more cost-effective The faster a dressing could bring about complete healing, the more likely that dressing was to be cost-effective.

  3. The evidence for many dressings is uncertain The authors found that the overall level of evidence for many dressings was uncertain or low quality. Aquacel Ag+ Extra™ is supported by RCT and real world evidence.

Contact us
timeline ;

Contact us

Are you currently in contact with a Convatec representative?
Select a Product Type*

We need your consent to continue

Your privacy is important to us. Please take a moment to read our privacy policy to understand how Convatec uses and protects your personal data. We never share your data with other companies without your permission.

We need your consent to continue

Your privacy is important to us. Please take a moment to read our privacy policy to understand how Convatec uses and protects your personal data. We never share your data with other companies without your permission.
You can manage your consent at any time by unsubscribing through a link in our emails, contacting us at 01244 284 882 (UK) or by email at uk.customerservice@convatec.com.
You can manage your consent at any time by unsubscribing through a link in our emails, contacting us at 01244 284 882 (UK) or by email at uk.customerservice@convatec.com.

*within 12 weeks

1. Beraldo S, Ljungqvist J, Rodger R, Hanson B, Saavedra C. Effectiveness of an enhanced silver-containing dressing in hard-to-heal venous leg ulcers: a randomised controlled trial. J Wound Care. 2025;34(3):170-178.
2. Meaume S, Truchetet F, Cambazard F, et al. A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers. Wound Repair and Regeneration. 2012;20(4):500-511. doi:10.1111/j.1524-475X.2012.00797.x
3. Holmes H, di Ruffano L, Kelly L, et al. [GID-HTE10041] - Topical Antimicrobial Dressings for Infected Leg Ulcers in People and 16 and over. Second Addendum.; 2025.
4. Holmes H, di Ruffano L, Kelly L, et al. [GID-HTE10041] - Topical Antimicrobial Dressings for Infected Leg Ulcers in People and 16 and over. External Assessment Group Report.; 2025.

AP-76329-GBR-ENG-v1 (v1.1)

You are leaving convatec.com

This Internet site may provide links or references to other sites but Convatec have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.

Do you wish to continue?